S 16, the Protecting Life on College Campus Act of 2023, prohibits federal funding for colleges and universities that host campus health clinics providing abortion drugs or abortions to students or employees. It requires these institutions to submit annual certifications confirming their clinics do not offer such services, with funding eligibility contingent on this compliance. The bill defines "abortion drugs" broadly as any medication intended to terminate a pregnancy (excluding specific medical exceptions), and clarifies that campus health clinics - not hospitals - are covered under this restriction. This policy directly affects public and private institutions of higher education receiving federal funds, altering their funding eligibility based on campus health service offerings.
This bill prohibits the U.S. Secretary of Energy from selling petroleum products from the Strategic Petroleum Reserve (SPR) to entities controlled by the Chinese Communist Party or to any buyer unless they guarantee the oil won't be exported to China. It directly affects the Department of Energy (which manages the SPR) and any companies or entities seeking to purchase SPR oil with potential Chinese ties. The key mechanism requires the Secretary to block sales to China-linked entities or impose strict export restrictions on all sales. The bill aims to prevent SPR oil from reaching China, without creating new programs or altering existing SPR management rules.
This bill prohibits abortions performed specifically because a prenatal test or diagnosis indicates the unborn child has Down syndrome. It makes it a federal crime for medical providers to perform such abortions, with potential penalties of up to five years in prison or fines, and allows civil lawsuits by affected individuals (like parents or the woman) seeking damages. The law requires medical professionals to report suspected violations to law enforcement and mandates courts to protect the privacy of women seeking such abortions. It explicitly states the bill does not create a right to abortion or affect existing abortion access, focusing solely on banning disability-based abortion decisions.
The Protect Funding for Women's Health Care Act prohibits federal funding for Planned Parenthood Federation of America and its affiliates, clinics, subsidiaries, or successors. It redirects these funds to other eligible health care providers - including community health centers, hospitals, and clinics that serve underserved populations - to ensure continued access to services like contraception, cancer screenings, prenatal care, and STI testing. The bill explicitly states it does not alter existing abortion funding restrictions or reduce overall federal support for women’s health services. This policy change aims to maintain funding availability for essential women’s health care while shifting resources away from Planned Parenthood.
This resolution declares that every state within the United States has the sovereign right to exclude any person who does not have the right to be there. It also declares that the states along the southern border (1) are being invaded by terrorists, narco-terrorist cartels, and criminal actors; and (2) have the sovereign and unilateral authority to defend themselves against such an invasion.
This bill blocks federal funding for colleges that operate or partner with campus health clinics providing abortion drugs or abortions to students or staff. It requires institutions receiving federal funds to annually certify that no such services are offered at their on-campus clinics. The law specifically excludes hospital-based clinics from coverage and defines "abortion drugs" as medications intended to terminate pregnancy (excluding specific medical exceptions). It directly affects public and private colleges receiving federal aid, as most institutions of higher education qualify for such funding.
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.
Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.
Standardizing Thresholds Of Penalties for Fentanyl Act or the STOP Fentanyl Act This bill reduces the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, imports, exports, or possesses with intent to distribute fentanyl. The bill also creates enhanced criminal penalties for certain violations involving fentanyl that was imported along the U.S.-Mexico border. Specifically, the bill reduces from 400 to 5 grams the fentanyl quantity and from 100 to 0.05 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for high-level first-time or repeat offenders. It also reduces from 40 to 0.5 grams the fentanyl quantity and from 10 to 0.005 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for low-level first-time or repeat offenders. Additionally, the bill creates enhanced mandatory minimum prison terms for importing or exporting fentanyl that was imported along the U.S.-Mexico border.
HR 330, the Title X Abortion Provider Prohibition Act, prohibits federal funding under the Title X family planning program for clinics that perform or fund abortions, except in cases of rape, incest, or when a physician certifies a life-threatening condition. It requires clinics receiving Title X funds to certify they do not provide or fund abortions (with the specified exceptions), and hospitals are exempt if they don't fund non-hospital abortion providers. The bill mandates annual reports to Congress listing all funded clinics, the number of abortions performed under exceptions (including rape/incest cases), and the certification dates for each clinic. This directly affects Title X-funded clinics nationwide that provide abortion services or fund such services, altering their eligibility for federal funding. The law aims to restrict federal support for abortion access within the Title X program while maintaining limited exceptions.
HR 271, the "Restoring Normalcy in America Act," directs the HHS Secretary to study vaccine effectiveness, treatments, pandemic transmission, preparedness, and the origins of COVID-19, requiring a report within one year. It terminates all emergency use authorizations for COVID-19 vaccines and treatments effective immediately upon enactment. The bill also mandates a GAO audit of all federal pandemic funding across HHS, FDA, and CDC, with a report due within a year. Additionally, it adds "failure to receive a COVID-19 vaccination" as a protected characteristic under civil rights laws, making it unlawful to discriminate in employment, public accommodations, or federally assisted programs based on vaccination status, and requires reinstatement for military members and federal employees discharged over vaccine refusal.
This bill prohibits the export or sale of petroleum products drawn from the U.S. Strategic Petroleum Reserve to specific countries and entities, including China, Russia, North Korea, Iran, and any nation under U.S. sanctions. It also bans exports to entities owned or controlled by these countries or the Chinese Communist Party. The Secretary of Energy must enforce this ban, though they may issue a national security waiver for specific exports. The bill requires the Secretary to issue implementing rules within 60 days of enactment. It directly affects the Secretary of Energy, oil exporters seeking to use the Strategic Petroleum Reserve, and the listed countries/entities.
